2013 Rieveschl Award for Distinguished Scientific Research: George Deepe, MD
UC is known for excellence in research, and George Deepe, MD, has played a part in that reputation with his contributions to infectious diseases research.
For over 30 years as a faculty member at UC, Deepe, who also served for 15 years as chief of the division of infectious diseases, has been a leading researcher and a world-recognized expert in the study of Histoplasma capsulatum, a pathogenic fungus that causes infection, particularly in the Ohio River Valley.
For his work, he has been selected as UCs 2013 recipient of the George Rieveschl Jr. Award for Distinguished Scientific Research. He was honored at the All-University Faculty Awards celebration April 17, 2013.
Deepe has consistently received federal and private funding for his research and has been awarded a number of honors, including the Research Career Development Award from the National Institute of Allergy and Infectious Diseases (NIAID) from 1987 to 1992 and the MERIT Award from the NIAID from 1997 to 2007.
In addition to his outstanding research portfolio, Deepe is heavily involved in mentoring graduate students and currently serves as associate director of the UC Medical Scientist Training Program.
He excels in research, education and clinical care but is known among his colleagues and mentees as being a fun, intelligent and caring personsomeone you can always come to with a problem.
One of his nominators wrote: "George is well known in our academic community for his great sense of humor, deep literary background, unstinting loyalty and enormous generosity of spirit.
Tags
Related Stories
UC students organize free health clinic in community
July 15, 2026
The University of Cincinnati student chapter of Remote Area Medical held its annual free health clinic July 11-12 at St. Xavier High School. Medical, dental and vision care was offered to adults and children, with no income requirements or insurance needed.
University of Cincinnati advances FLASH radiation therapy with new clinical trial
July 15, 2026
UC Cancer Center researchers led the FAST-02 trial, showing ultra-high-dose-rate FLASH proton therapy near the heart and lungs safely reduced pain from thoracic bone metastases.
New UC Center for Alzheimer's and Neurodegenerative Diseases Research to advance dementia research, treatment and education
July 14, 2026
The University of Cincinnati and UC Health are launching the Center for Alzheimer's and Neurodegenerative Diseases Research (CANDR) to advance dementia research, clinical care and brain health education.